References
- Fahal AH. Mycetoma. Khartoum Med J 2011; 4: 514–523.
- Fahal AH. Management of mycetoma. Expert Rev Dermatol 2010; 5: 87–93.
- Ahmed A, Adelmann D, Fahal A, et al. Environmental occurrence of Madurella mycetomatis, the major agent of human eumycetoma in Sudan. J Clin Microbiol 2002; 40: 1031–1036.
- Ahmed A, van de Sande WWJ, Fahal A, et al. Management of mycetoma: major challenge in tropical mycoses with limited international recognition. Curr Opin Infect Dis 2007; 20: 146–151.
- Fahal AH. Mycetoma: a thorn in the flesh. Trans R Soc Trop Med Hyg 2004; 98: 3–11.
- Fahal AH, Hassan MA. Mycetoma. Br J Surg 1992; 79: 1138–1141.
- Fahal AH, el Toum EA, el Hassan AM, Mahgoub ES, Gumaa SA. The host tissue reaction to Madurella mycetomatis: new classification. J Med Vet Mycol 1995; 33: 15–17.
- Chensue SW, Warmington KS, Allenspach EJ, et al. Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation. J Immunol 1999; 163: 165–173.
- Calich VL, Kashino SS. Cytokines produced by susceptible and resistant mice in the course of Paracoccidioides brasiliensisinfection. Braz J Med Biol Res 1998; 31: 615–623.
- Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 1981; 75: 816–821.
- el Hassan AM, Fahal AH, Ahmed AO, Ismail A, Veress B. The immunopathology of actinomycetoma lesions caused by Streptomyces somaliensis. Trans R Soc Trop Med Hyg 2001; 95: 89–92.
- van de Sande WW, Fahal A, Verbrugh H, van Belkum A. Polymorphisms in genes involved in innate immunity predispose toward mycetoma susceptibility. J Immunol 2007; 179: 3065–3074.
- van de Sande WW, Fahal A, Tavakol M, van Belkum A. Polymorphisms in catechol-O-methyltransferase and cytochrome p450 subfamily 19 genes predispose towards Madurellamycetomatis-induced mycetoma susceptibility. Med Mycol 2010; 48: 959–968.
- Selvaraj P, Alagarasu K, Singh B, Afsal K. CCL5 (RANTES) gene polymorphisms in pulmonary tuberculosis patients of south India. Int J Immunogenet 2011; 38: 397–402.
- Sanchez-Castanon M, Baquero IC, Sanchez-Velasco P, et al. Polymorphisms in CCL5 promoter are associated with pulmonary tuberculosis in northern Spain. Int J Tuberc Lung Dis 2009; 13: 480–485.
- Vesosky B, Rottinghaus EK, Stromberg P, Turner J, Beamer G. CCL5 participates in early protection against Mycobacterium tuberculosis. J Leukoc Biol 2010; 87: 1153–1165.
- Liu H, Chao D, Nakayama EE, et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 1999; 96: 4581–4585.
- An P, Nelson GW, Wang L, et al. Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proc Natl Acad Sci USA 2002; 99: 10002–10007.
- Bozzi A, Pereira PP, Reis BS, et al. Interleukin-10 and tumor necrosis factor-alpha single nucleotide gene polymorphism frequency in paracoccidioidomycosis. Hum Immunol 2006; 67: 931–939.
- Balloy V, Chignard M. The innate immune response to Aspergillus fumigatus. Microbes Infect 2009; 11: 919–927.
- Costa DL, Dias-Melicio LA, Acorci MJ, et al. Effect of interleukin-10 on the Paracoccidioides brasiliensis killing by gamma-interferon activated human neutrophils. Microbiol Immunol 2007; 51: 73–80.